Complete guide to cannabis laws, penalties, and travel advice
Peru's cannabis law sits at a carefully calibrated midpoint between prohibition and tolerance. The country maintains serious criminal penalties for trafficking and supply while creating a de facto personal use tolerance through Article 299 of the Penal Code — a provision that has been in place in various forms since 1991 and was reaffirmed by a Constitutional Tribunal ruling in 2018.
Article 299 specifies that personal possession of up to 8 grams of cannabis flower, or up to 2 grams of cannabis derivatives, does not constitute a criminal offence. The article includes an important caveat: this protection is removed if the individual possesses two or more different controlled substances simultaneously, or if the circumstances suggest the cannabis is intended for supply rather than personal use. In practice, this means that a tourist carrying cannabis alongside any other controlled substance — including recreational quantities of cocaine, which has its own threshold under Article 299 — loses the decriminalisation protection entirely.
Medical cannabis was legalised through Law 30681, passed unanimously by Peru's Congress in October 2017. The law explicitly permits the importation, cultivation, research, production, and commercialisation of cannabis and its derivatives for medicinal and therapeutic use under a regulatory framework administered by DIGEMID (Dirección General de Medicamentos, Insumos y Drogas), Peru's medicines regulatory authority.
Peru's drug enforcement environment is shaped by its geography: the country shares borders with Bolivia and contains portions of the upper Amazon basin, making it both a significant cannabis cultivation zone and a transshipment corridor for cocaine trafficking. This context means drug enforcement authorities maintain heightened operational levels, which can affect how cannabis possession cases are handled in practice even when the law favours decriminalisation.
Peru's penalty framework creates a clear threshold at 8 grams for cannabis flower. Below this threshold, possession is decriminalised. Above it, the full criminal framework of the Law Against Trafficking in Illicit Drugs (Legislative Decree 824 and subsequent amendments) applies.
| Offence Category | Quantity Threshold | Legal Status | Penalty Range |
|---|---|---|---|
| Personal possession — flower | Up to 8g | Decriminalised (Art. 299) | No criminal penalty |
| Personal possession — derivatives | Up to 2g | Decriminalised (Art. 299) | No criminal penalty |
| Possession over threshold | 8g–100g | Criminal — supply presumed | 1–8 years |
| Supply / Dealing | Any quantity | Criminal — trafficking | 8–15 years |
| Aggravated trafficking | Large scale / organised crime | Criminal — aggravated | Up to 25 years |
| Cultivation (unlicensed) | Any scale | Criminal | 8–15 years |
Peru's anti-narcotics police (DIRANDRO) have broad powers of search and detention. Field tests used to assess cannabis quantity are not always precise, meaning a border case slightly above 8 grams can result in arrest and pre-trial detention even if formal charges are later dropped. Pre-trial detention in Peruvian prisons is a serious hardship to avoid at all costs.
Law 30681 created a comprehensive framework for medical cannabis in Peru. DIGEMID operates as the regulatory gatekeeper, issuing authorisations for importation and production. Patients wishing to access medical cannabis must obtain authorisation from a licensed physician and register with DIGEMID before purchasing or using any cannabis product.
The programme covers non-smokable cannabis preparations only — oils, tinctures, capsules, and suppositories. Smoking cannabis for medical purposes is not covered under the medical programme. Patients may access CBD-dominant oils relatively easily; THC-containing products require more stringent documentation of therapeutic need.
Medical cannabis pharmacies licensed under Law 30681 operate in Lima and several major regional cities. Importation licences have been issued to several domestic cannabis companies, and Peru has seen modest growth in licensed cannabis cultivation for pharmaceutical-grade oil production. Companies operating under DIGEMID cultivation licences must maintain secure facilities, track-and-trace systems, and Good Manufacturing Practice (GMP) certification.
Conditions approved for medical cannabis access include epilepsy and seizure disorders, chronic pain, multiple sclerosis, cancer-related pain and nausea, PTSD, and several degenerative neurological conditions. Approval rates for physician-recommended medical cannabis authorisations are reported to be high by DIGEMID.
Unlicensed cannabis cultivation in Peru is a serious criminal offence categorised under the same trafficking provisions as supply — carrying 8–15 years imprisonment. Peru maintains significant coca and cannabis eradication programmes in the Amazon and Andean regions, conducted by CORAH (Control y Reducción del Cultivo de la Coca en el Alto Huallaga) and supported by US Drug Enforcement Administration funding.
Peru is a significant global cannabis cultivator despite the legal prohibition. The Huallaga Valley and Upper Amazon basin contain extensive illegal cannabis grows operated primarily for domestic consumption and regional trafficking networks. Eradication operations are conducted periodically but face the fundamental challenge of remoteness and limited enforcement reach in jungle regions.
Licensed cultivation under the medical cannabis framework (Law 30681) requires a specific DIGEMID cultivation licence, fulfilment of security and tracking requirements, and proof of an end-use contract with a licensed processor or pharmaceutical manufacturer. Individual patient cultivation is not permitted under the medical framework — unlike Argentina's REPROCANN system, Peru's medical programme is production-focused rather than patient-cultivation-focused.
Peru's anti-trafficking law framework is among the most severe in South America. The base offence of cannabis trafficking — any sale or supply outside the licensed medical framework — carries 8–15 years. Aggravated trafficking offences carrying up to 25 years include: operation as part of an organised criminal network, use of minors to commit the offence, supply in or near educational institutions, and trafficking across international borders.
Peru cooperates extensively with US DEA, the UNODC, and bilateral partners Colombia, Bolivia, and Brazil on anti-narcotics enforcement. The International Airport Jorge Chávez in Callao (Lima) is a major narcotics interception point, with dogs, scanners, and profiling-based enforcement. Trafficking-related prosecutions often include asset forfeiture of vehicles, property, and financial assets under Law 27765.
Cannabis use in Peru predates European colonisation, with evidence of hemp cultivation and cannabis use in coastal and highland communities stretching back centuries. The plant arrived in South America via Portuguese and Spanish colonial routes and quickly integrated into existing botanical and ceremonial practices in some Andean communities. However, cannabis does not hold the same deep ceremonial significance in Peru that it does in some South Asian and Caribbean cultural traditions — that role is occupied more prominently by coca leaf.
Modern cannabis culture in Peru is concentrated in Lima, particularly in bohemian districts like Barranco and Miraflores, where a visible cannabis reform movement operates. Annual Global Marijuana March events in Lima typically draw several thousand participants and have been held without incident, demonstrating tolerance by Lima Metropolitan Police. Cannabis cafés do not legally exist, but informal social use in private settings is common among young urban populations.
Peru's tourist industry intersects with cannabis primarily in Cusco and the Sacred Valley, where some traveler-oriented services make cannabis available informally. The combination of altitude, tourist concentration, and police activity in Cusco creates a specific risk profile for travelers that differs from Lima.
Peru presents a medium-to-high risk environment for cannabis-related activity. The 8-gram decriminalisation threshold provides a legal buffer but is unreliable in practice for foreign nationals, particularly at international entry points where federal enforcement applies.
The Lima international airport is a narcotics enforcement priority. Arriving or departing with any cannabis — including quantities under 8 grams — risks confiscation, detention, and potential federal trafficking charges. Airport authorities interpret any cannabis in a traveler's luggage as potential international trafficking regardless of quantity.
Cusco presents a unique risk because police in tourist-heavy areas are aware that international visitors may be unaware of or indifferent to local laws. Extortion attempts using cannabis as a pretext are documented in traveler reports. Carrying any cannabis in Cusco's historic centre is strongly inadvisable.
In Lima, the decriminalisation threshold is more likely to be applied in practice, particularly in middle-class neighbourhoods. Even so, police stop-and-search powers are broad, and a foreign national carrying cannabis faces questions about possession purpose that a Peruvian citizen invoking Article 299 might not. The safest approach is to carry nothing.
Peru's Medical Cannabis Law (30681) received a significant secondary regulatory framework in 2019 and further licensing guidance in 2021 and 2022. The medical programme has expanded substantially: from fewer than 20 licensed operators in 2019 to over 80 by 2023, including cultivation, processing, and dispensing entities. Patient access has improved materially, though cost remains a barrier for many Peruvians.
Decriminalisation reform advocates in Peru have lobbied the Constitutional Tribunal to extend Article 299 protections more explicitly to foreigners and to raise the threshold amounts. As of the current review date, no successful constitutional challenge has changed the threshold levels. The Peruvian Congress has not advanced any full legalisation bill to a vote.
Industrial hemp cultivation has entered Peru's agricultural and regulatory discussion primarily through the lens of the medical cannabis law's cultivation licensing provisions. Law 30681 created a pathway for licensed cannabis cultivation under DIGEMID oversight — a framework that can in principle accommodate hemp as well as pharmaceutical-grade THC-containing cannabis. However, Peru has not established a standalone industrial hemp regulatory framework, and the legal distinction between hemp and narcotics cannabis is not clearly established in Peruvian statute.
Peru's geography offers compelling arguments for hemp cultivation development. The country contains extraordinary agro-ecological diversity — from coastal desert to Andean highlands to Amazon basin — and different hemp varieties suited to fibre, seed, or CBD production could theoretically thrive in different Peruvian regions. Andean highland communities in particular, who have historically cultivated illicit cannabis, have been identified by development researchers as potential beneficiaries of a licit hemp economy if a regulatory pathway were created.
DEVIDA (the Peruvian national commission for development and life without drugs) — an agency primarily focused on coca leaf and cocaine trafficking reduction — has acknowledged that regulated hemp could provide an alternative livelihood for some Andean communities currently involved in illicit cannabis production. International development organisations including UNODC's alternative development programme have discussed hemp as a component of broader rural development strategies in Peruvian Andean communities.
No standalone hemp cultivation licences have been issued outside the pharmaceutical cannabis framework as of the current review date. Advocates for Peruvian hemp industry development argue that a clear industrial hemp regulation — with specified THC thresholds and cultivation, processing, and export rules — would unlock significant agricultural export potential for Peru while simultaneously reducing the scale of illicit cannabis cultivation in highland regions. Legislative progress on this question remains slow but the economic rationale is increasingly recognised within Peruvian agricultural policy circles.
Personal possession of up to 8 grams of cannabis flower is decriminalised under Article 299 of the Penal Code. Trafficking, cultivation, and supply remain serious crimes. A medical cannabis programme under Law 30681 has been active since 2017.
Up to 8 grams of cannabis flower or 2 grams of cannabis derivatives without criminal prosecution under Article 299. This protection is removed if multiple controlled substances are carried simultaneously. The protection is not reliably applied to foreign nationals, especially at airports.
Cannabis trafficking carries 8–15 years imprisonment under the basic offence. Aggravated trafficking — involving organised crime, use of minors, or quantities above threshold amounts — carries up to 25 years imprisonment.
Yes. Law 30681 legalised medical cannabis in 2017. Patients obtain authorisation through DIGEMID for oils, tinctures, and non-smokable preparations. The programme covers epilepsy, chronic pain, cancer, multiple sclerosis, and other conditions with over 80 licensed operators nationally.